Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial proteins, nucleic acids, and membranes represent the primary structural and functional targets for antimicrobial agents, including antibiotics, antivirals, and biocides (NIH, 2021). Proteins serve as enzymes for metabolism and structural components, while nucleic acids (DNA and RNA) carry the genetic information necessary for replication and protein synthesis (StatPearls, 2023). The microbial membrane or cell wall provides a physical barrier and maintains osmotic pressure; its disruption leads to cell lysis (PubMed, 2020). Drugs targeting these components work by inhibiting protein synthesis, disrupting genetic replication, or compromising the integrity of the cell envelope, leading to pathogen death or growth inhibition (CDC, 2022). This broad categorization is often used to describe the multi-target mechanism of action of non-specific biocides like alcohols and oxidizing agents, which cause widespread damage across these molecular classes (WHO, 2020).
Denaturation of proteins, disruption of lipid membranes, and oxidative damage to or inhibition of nucleic acid synthesis.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial proteins, nucleic acids, and membranes.